Research Article
Gastric Mucinous Cancer Histology: Clinicopathological Characteristics and Prognostic Value
Table 1
Comparison of clinicopathological features between MC and WMDC patients for gastric cancer.
| | | MC (68 cases) | WMDC (329 cases) | value | value |
| | Age | | | 0.571 | 0.450 | | ≤60 years | 34 (50.0%) | 148 (45.0%) | | | | >60 years | 34 (50.0%) | 181 (55.0%) | | | | Gender | | | 3.513 | 0.061 | | Male | 44 (64.7%) | 249 (75.5%) | | | | Female | 24 (35.3%) | 80 (24.3%) | | | | Tumor diameter | | | 8.867 | 0.003 | | ≤5 cm | 28 (41.2%) | 200 (60.8%) | | | | >5 cm | 40 (58.8%) | 129 (39.2%) | | | | Tumor location | | | 1.470 | 0.479 | | Upper 1/3 | 25 (36.8%) | 132 (40.1%) | | | | Middle 1/3 | 7 (10.3%) | 47 (14.3%) | | | | Lower 1/3 | 36 (52.9%) | 150 (45.6%) | | | | Borrmann type | | | 7.399 | 0.060 | | Borrmann I | 8 (11.8%) | 30 (9.1%) | | | | Borrmann II | 12 (17.6%) | 113 (34.3%) | | | | Borrmann III | 41 (60.3%) | 162 (49.2%) | | | | Borrmann IV | 7 (10.3%) | 24 (7.3%) | | | | Depth of invasion | | | 22.274 | <0.001 | | | 2 (2.9%) | 60 (18.2%) | | | | | 7 (10.3%) | 77 (23.4%) | | | | | 33 (48.5%) | 125 (38.0%) | | | | | 26 (38.2%) | 67 (20.4%) | | | | Lymph node metastasis | | | 10.130 | 0.017 | | | 13 (19.1%) | 121 (36.8%) | | | | | 15 (22.1%) | 76 (23.1%) | | | | | 23 (33.8%) | 82 (24.9%) | | | | | 17 (25.0%) | 50 (15.2%) | | | | TNM stage | | | 10.827 | 0.013 | | I | 6 (8.8%) | 82 (24.9%) | | | | II | 11 (16.2%) | 58 (17.6%) | | | | III | 28 (41.2%) | 119 (36.2%) | | | | IV | 23 (33.8%) | 70 (21.3%) | | | | Peritoneal dissemination | | | 11.849 | 0.001 | | P (+) | 20 (29.4%) | 42 (12.8%) | | | | P (−) | 48 (70.6%) | 287 (87.2%) | | | | Hepatic metastasis | | | 0.386 | 0.535 | | H (+) | 3 (4.4%) | 21 (6.4%) | | | | H (−) | 65 (95.6%) | 308 (93.6%) | | | | Curability | | | 6.440 | 0.011 | | Curative | 43 (63.2%) | 256 (77.8%) | | | | Noncurative | 25 (36.8%) | 73 (22.2%) | | |
|
|
